Blog - Page 2569 of 5708

MondayMay 23, 2016 9:23 am

International Stem Cell Corp. (ISCO) Teams with Leading Cryogenic Logistics Provider for Impending Clinical Trial

Before the opening bell, Cryoport, Inc. (NASDAQ: CYRX), a premier provider of cryogenic logistics solutions to the life sciences industry, announced a strategic partnership with International Stem Cell Corp. (OTCQB: ISCO) through which it will provide global logistics support to ISCO for its impending phase I clinical trial. ISCO received authorization to begin a phase I/IIa clinical trial of its human parthenogenetic stem cell-derived neural stem cells (ISC-hpNSC) in patients with moderate to severe Parkinson’s disease from the Therapeutic Goods Administration of Australia in December, and the company commenced patient enrollment for the study earlier this year. As the premier…

MondayMay 23, 2016 8:43 am

Laguna Blends Inc. (LAGBF) Offers Treasure Chest of Opportunity to Aspiring Entrepreneurs and Affiliates

Laguna Blends Inc. (OTC: LAGBF) asks, “Have you ever dreamed of owning your own business - full-time or part-time?” The very thought conjures up a multitude of emotions over a wide spectrum of aspirations and ambitions. ‘What if you could be involved in a home-based business and didn’t have to be good at sales?’ For the person who is moved to take action as a result of these questions, his or her thought process quickly and naturally turns to the obvious – ‘What product or service energizes me, and, if I can chart my own course, I may as well…

FridayMay 20, 2016 4:04 pm

International Stem Cell Corp. (ISCO) Covered in Report by Edison Investment Research

Earlier this week, Edison Investment Research, a leading independent investment intelligence firm, commenced coverage of International Stem Cell Corp. (OTCQB: ISCO). In the initial report, Edison gives prospective investors an in-depth look at ISCO’s current market position, including its impending Phase I/IIa clinical trials for the treatment of Parkinson’s disease, as well as its revenue-generating subsidiaries, Lifeline Skin Care and Lifeline Cell Technology, which Edison suggests ‘provide a floor under ISCO’s current valuation, creating an essentially free option on the PD candidate’. To view the full report, visit http://dtn.fm/fIF6B Leveraging its innovative human parthenogenetic stem cell (hpSC) technology, ISCO has…

FridayMay 20, 2016 2:36 pm

Take your NextTrip with Monaker Group (MKGI)

Monaker Group, Inc. (OTCQB: MKGI) is traveling far and fast. In a recent interview with investor relations firm MissionIR, CEO Bill Kerby recapitulated the company’s most recent achievements and its prospects in the growing online travel-booking marketplace. Statista estimates (http://dtn.fm/6rOeB) that global international tourism revenue in 2014 was $1,245 billion. Of that, about 27 percent, or $340 billion, was online travel-booking revenues. Online travel agency (OTA) revenues are expected to continue growing at 12 percent annually, according to this Forbes piece (http://dtn.fm/BIjt4). OTA websites have evolved to accommodate this increased demand and now may offer information and access to airlines,…

FridayMay 20, 2016 2:02 pm

Rennova Health, Inc. (RNVA) Enhancing Speed and Accuracy of Diagnostic Testing and Record Processing

Rennova Health, Inc. (NASDAQ: RNVA), based in West Palm Beach, Florida, specializes in providing a full range of medical and administrative technologies and services to U.S. healthcare providers. The company’s suite of products and services are designed to enhance treatment success while streamlining customer and financial information processing, improving both patient and financial outcomes. Rennova Health provider solutions include: Diagnostic Solutions – Rennova offers comprehensive clinical testing services, including advanced toxicology and esoteric lab services such as urine testing for abuse of drugs and prescription medications, in addition to bacteriology, serology, immunology, hematology and neurotransmitter testing. Brands: Medytox Diagnostics Revenue…

FridayMay 20, 2016 1:31 pm

International Stem Cell Corp. (ISCO) Introducing a New Era of Medicine with its First Phase of Clinical Trials

International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on early-stage cell therapy. ISCO uses stem cells to treat a variety of diseases, including those of the eyes, the nervous system, and the liver, among others. The scientists at ISCO treat severe diseases with state-of-the-art technology. The aim of the company is to create therapeutic products from its own intellectual property. With this in mind, ISCO also owns two subsidiary companies. Lifeline Skin Care Inc. is a business that develops and manufactures skin care products, while Lifeline Cell Technology, LLC is a research products business that develops…

FridayMay 20, 2016 12:49 pm

Oakridge Global Energy Solutions, Inc. (OGES) Setting Its Sights on Strategic Advances

Oakridge Global Energy Solutions (OTCQB: OGES) began life as a true research and development company, and now, 30 years later, it has grown to become the developer of some of the world's best energy solutions. In that time, Oakridge has also advanced its business strategies considerably in order to become a global leader in the innovation, development, manufacturing and marketing of disruptive energy storage technology for military, civilian and medical uses. The past couple of years have been especially significant for Oakridge, with corporate milestones including: The company successfully finalized a major two-year restructuring plan at the end of 2015.…

FridayMay 20, 2016 12:09 pm

OurPet’s Company (OPCO) Combining Record Financial Performance with Continued Innovation to Bolster Leadership Position in Pet Industry

Earlier this month, OurPet’s Company (OTCQX: OPCO) made headlines when it reported record financial results for the three months ended March 31, 2016. The company’s first quarter net revenue increased by 10.3 percent from the previous year, totaling $6.17 million. Similarly, OPCO’s net income rose by 24.7 percent over the previous year to a record total of $266,581. These strong results continue to highlight the company’s success in promoting growth through multiple sales channels. OPCO’s sales through e-commerce channels were up 14 percent over the previous year, while sales through food, drug and mass retail channels grew by eight percent.…

FridayMay 20, 2016 8:37 am

Giggles N’ Hugs, Inc. (GIGL) Riding Organic Wave in Restaurant Industry

It’s safe to say that demand for organic food has transcended the category of niche and entered into the mainstream. In 1990, domestic sales of organic food and beverages totaled just $1 billion, but, by 2009, that figure had grown to $24.8 billion, according to the American Organic Trade Association. For comparison, the conventional food market grew by less than two percent over the same period. Rising awareness regarding the health benefits of eating organic, along with growing health concerns among consumers, is expected to continue to drive rapid growth for the organic market, with TechSci Research forecasting a compound…

ThursdayMay 19, 2016 1:39 pm

Alternet Systems, Inc.’s (ALYI) Big Data Division Gives SMEs a Crystal Ball

This month marks the 74th anniversary of the start of publication of a series of short stories that was later compiled into Isaac Asimov’s classic Foundation science fiction trilogy. Asimov’s intensely thought-provoking work is premised on what, today, we know as big data. It is set in the future when humans have colonized the entire Milky Way. The galaxy’s large population numbers make it possible to apply advanced mathematical and statistical techniques to predict mankind’s future. Large numbers make predictions more accurate. Asimov’s insight was that, even though human behavior on an individual level is subject to our idiosyncratic natures,…

Site Search

Company Search